RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Advanced Oncotherapy Stock

Advanced Oncotherapy Employees 2024

Advanced Oncotherapy Employees

129

Ticker

AVO.L

ISIN

GB00BD6SX109

WKN

A2AL9X

In 2024, Advanced Oncotherapy employed 129 people, a 0% change from the 0 number of employees in the previous year.

Advanced Oncotherapy Aktienanalyse

What does Advanced Oncotherapy do?

Advanced Oncotherapy PLC is a therapeutic company in London specializing in the development of advanced and precise radiation therapy solutions. The company was founded in 2005 and has since developed a revolutionary technology that allows for the treatment of cancer cells with the highest precision and minimal to no damage to surrounding tissue. The business model of Advanced Oncotherapy aims to offer innovative technology solutions that benefit patients throughout their medical cancer treatment. The various facets of the company include research and development, production, sales and distribution, as well as clinical trials. Advanced Oncotherapy focuses on a direct customer-customer relationship by offering customers interesting treatment options tailored to the patient's needs. The flagship product of Advanced Oncotherapy is the LIGHT radiation therapy system, which is unique worldwide due to its precision, accuracy, and effectiveness in the treatment of cancer. This system allows oncologists and radiologists to perform innovative radiation therapy that promises better treatment outcomes. The LIGHT technology is based on the principles of intensity-modulated radiation therapy (IMRT) and next-generation particle therapy (NGPT). By using proton beams, the radiation therapy can be focused directly on a specific region of the body where cancer tissue is spreading. Advanced Oncotherapy offers a wide range of radiation therapy services to its customers. This includes proton accelerators (PROTON), PET/CT systems (positron emission tomography/computed tomography), CT scanners (computed tomography), and other tools and devices. The product line has been specifically developed for the precise irradiation of tumors as well as the diagnosis of cancer and other related diseases. Customers of Advanced Oncotherapy are primarily hospitals, medical centers, and health authorities. In recent years, Advanced Oncotherapy has collaborated closely with various partners such as CERN (European Organization for Nuclear Research), the Royal Marsden Hospital, University College London, and other institutions to constantly improve and further develop its technology and products. Milestones in the company's history include the CE marking for the LIGHT system and support for clinical trials by research-intensive university hospitals. The future of Advanced Oncotherapy looks promising, with a strong growth forecast for the global radiation therapy market. With an increasing demand for innovative solutions in cancer treatment, the company can look forward to a growing customer base and an increasing number of partnerships and collaborations. Advanced Oncotherapy will continue to focus on continuously optimizing its technology to provide cancer patients with the best treatment options. Advanced Oncotherapy ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Advanced Oncotherapy's Employee Base

Advanced Oncotherapy's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Advanced Oncotherapy's operational capacity and future potential.

Year-to-Year Comparison

Assessing Advanced Oncotherapy's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Advanced Oncotherapy's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Advanced Oncotherapy’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Advanced Oncotherapy stock

How many employees does Advanced Oncotherapy have this year?

Advanced Oncotherapy has 129 undefined employees this year.

How many employees did Advanced Oncotherapy have compared to the previous year?

Compared to the previous year, Advanced Oncotherapy had 0% more employees.

What impact did the number of employees have on the company Advanced Oncotherapy?

The number of employees has a direct impact on the efficiency and productivity of Advanced Oncotherapy. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Advanced Oncotherapy?

The number of employees can also have an impact on investors of Advanced Oncotherapy, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Advanced Oncotherapy affect the company?

An increase in equity of Advanced Oncotherapy can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Advanced Oncotherapy's equity affect the company?

A reduction in equity of Advanced Oncotherapy can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Advanced Oncotherapy?

Some factors that can influence the equity of Advanced Oncotherapy include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Advanced Oncotherapy so important for investors?

The equity of Advanced Oncotherapy is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Advanced Oncotherapy influence the company?

The number of employees at Advanced Oncotherapy can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Advanced Oncotherapy evolved in recent years?

In recent years, the number of employees at Advanced Oncotherapy has changed by NaN.

How many employees does Advanced Oncotherapy currently have?

Advanced Oncotherapy currently has 129 undefined employees.

Why is the number of employees important for investors of Advanced Oncotherapy?

The number of employees is important for investors of Advanced Oncotherapy as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Advanced Oncotherapy take to change the number of employees?

To change the number of employees, Advanced Oncotherapy can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Advanced Oncotherapy pay?

Over the past 12 months, Advanced Oncotherapy paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Advanced Oncotherapy is expected to pay a dividend of 0 GBP.

What is the dividend yield of Advanced Oncotherapy?

The current dividend yield of Advanced Oncotherapy is .

When does Advanced Oncotherapy pay dividends?

Advanced Oncotherapy pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Advanced Oncotherapy?

Advanced Oncotherapy paid dividends every year for the past 0 years.

What is the dividend of Advanced Oncotherapy?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Advanced Oncotherapy located?

Advanced Oncotherapy is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanced Oncotherapy kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanced Oncotherapy from 9/17/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.

When did Advanced Oncotherapy pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Advanced Oncotherapy in the year 2023?

In the year 2023, Advanced Oncotherapy distributed 0 GBP as dividends.

In which currency does Advanced Oncotherapy pay out the dividend?

The dividends of Advanced Oncotherapy are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Advanced Oncotherapy

Our stock analysis for Advanced Oncotherapy Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanced Oncotherapy Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.